Wells Fargo’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.9K Sell
7,543
-3,334
-31% -$13.2K ﹤0.01% 5243
2025
Q1
$75.9K Buy
10,877
+122
+1% +$852 ﹤0.01% 4789
2024
Q4
$158K Buy
10,755
+8,684
+419% +$127K ﹤0.01% 4448
2024
Q3
$39.6K Sell
2,071
-477
-19% -$9.13K ﹤0.01% 5026
2024
Q2
$44.9K Buy
+2,548
New +$44.9K ﹤0.01% 4976